Literature DB >> 22213025

Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008.

Maxine M Denniston1, R Monina Klevens, Geraldine M McQuillan, Ruth B Jiles.   

Abstract

UNLABELLED: Many persons infected with hepatitis C virus (HCV) are unknown to the healthcare system because they may be asymptomatic for years, have not been tested for HCV infection, and only seek medical care when they develop liver-related complications. We analyzed data from persons who tested positive for past or current HCV infection during participation in the National Health and Nutrition Examination Survey (NHANES) from 2001 through 2008. A follow-up survey was conducted 6 months after examination to determine (1) how many participants testing positive for HCV infection were aware of their HCV status before being notified by NHANES, (2) what actions participants took after becoming aware of their first positive test, and (3) participants' knowledge about hepatitis C. Of 30,140 participants tested, 393 (1.3%) had evidence of past or current HCV infection and 170 (43%) could be contacted during the follow-up survey and interviewed. Only 49.7% were aware of their positive HCV infection status before being notified by NHANES, and only 3.7% of these respondents reported that they had first been tested for HCV because they or their doctor thought they were at risk for infection. Overall, 85.4% had heard of hepatitis C; correct responses to questions about hepatitis C were higher among persons 40-59 years of age, white non-Hispanics, and respondents who saw a physician after their first positive HCV test. Eighty percent of respondents indicated they had seen a doctor about their first positive HCV test result.
CONCLUSION: These data indicate that fewer than half of those infected with HCV may be aware of their infection. The findings suggest that more intensive efforts are needed to identify and test persons at risk for HCV infection.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22213025      PMCID: PMC4586034          DOI: 10.1002/hep.25556

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

Review 1.  Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas.

Authors:  James E Everhart; Constance E Ruhl
Journal:  Gastroenterology       Date:  2009-02-24       Impact factor: 22.682

2.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

3.  Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the US.

Authors:  Ramsey Cheung; Ajitha Mannalithara; Gurkirpal Singh
Journal:  Dig Dis Sci       Date:  2010-02-26       Impact factor: 3.199

Review 4.  Natural history of chronic hepatitis C.

Authors:  Leonard B Seeff
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

5.  Identification of patients with hepatitis C virus infection in New Haven County primary care practices.

Authors:  Victor J Navarro; Thomas E St Louis; Beth P Bell
Journal:  J Clin Gastroenterol       Date:  2003 May-Jun       Impact factor: 3.062

6.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-10-16

Review 7.  Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force.

Authors:  Roger Chou; Elizabeth C Clark; Mark Helfand
Journal:  Ann Intern Med       Date:  2004-03-16       Impact factor: 25.391

8.  A validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache.

Authors:  Hugh Schuckman; Susan Hazelett; Carol Powell; Sheila Steer
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

9.  Identification and management of hepatitis C patients in primary care clinics.

Authors:  Thomas M Shehab; Mauricio Orrego; Renu Chunduri; Anna S F Lok
Journal:  Am J Gastroenterol       Date:  2003-03       Impact factor: 10.864

10.  Public health impact of antiviral therapy for hepatitis C in the United States.

Authors:  Michael L Volk; Rachel Tocco; Sameer Saini; Anna S F Lok
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.298

View more
  157 in total

1.  Duplicate hepatitis C antibody testing in New York City, 2006-2010.

Authors:  Victoria Tsai; Katherine Bornschlegel; Emily McGibbon; Stephen Arpadi
Journal:  Public Health Rep       Date:  2014 Nov-Dec       Impact factor: 2.792

2.  Awareness of Hepatitis C Virus Seropositivity and Chronic Infection in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Mark H Kuniholm; Molly Jung; Julia Del Amo; Gregory A Talavera; Bharat Thyagarajan; Ronald C Hershow; Oriana M Damas; Robert C Kaplan
Journal:  J Immigr Minor Health       Date:  2016-12

3.  Hepatitis C-Related Mortality Among American Indian/Alaska Native Persons in the Northwestern United States, 2006-2012.

Authors:  Sarah M Hatcher; Sujata Joshi; Byron F Robinson; Thomas Weiser
Journal:  Public Health Rep       Date:  2019-11-25       Impact factor: 2.792

4.  Detecting Hepatitis B and C by Combined Public Health and Primary Care Birth Cohort Testing.

Authors:  Jeanne Heil; Christian J P A Hoebe; Jochen W L Cals; Henriëtte L G Ter Waarbeek; Inge H M van Loo; Nicole H T M Dukers-Muijrers
Journal:  Ann Fam Med       Date:  2018-01       Impact factor: 5.166

Review 5.  Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.

Authors:  Megan G Hofmeister; Elizabeth M Rosenthal; Laurie K Barker; Eli S Rosenberg; Meredith A Barranco; Eric W Hall; Brian R Edlin; Jonathan Mermin; John W Ward; A Blythe Ryerson
Journal:  Hepatology       Date:  2018-11-06       Impact factor: 17.425

6.  Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City.

Authors:  Kelly Quinn; Chunki Fong; Honoria Guarino; Pedro Mateu-Gelabert
Journal:  Drug Alcohol Depend       Date:  2018-11-28       Impact factor: 4.492

Review 7.  Hepatitis C virus: an overview for dental health care providers.

Authors:  R Monina Klevens; Anne C Moorman
Journal:  J Am Dent Assoc       Date:  2013-12       Impact factor: 3.634

Review 8.  Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade.

Authors:  Heidi Barth
Journal:  World J Hepatol       Date:  2015-04-18

9.  Building a Community - Academic Partnership to Enhance Hepatitis C Virus Screening.

Authors:  R Irvin; A McAdams-Mahmoud; D Hickman; J Wilson; W Fenwick; I Chen; N Irvin; O Falade-Nwulia; M Sulkowski; R Chaisson; D L Thomas; S H Mehta
Journal:  J Community Med Health Educ       Date:  2016-05-30

10.  Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.

Authors:  A Blythe Ryerson; Christie R Eheman; Sean F Altekruse; John W Ward; Ahmedin Jemal; Recinda L Sherman; S Jane Henley; Deborah Holtzman; Andrew Lake; Anne-Michelle Noone; Robert N Anderson; Jiemin Ma; Kathleen N Ly; Kathleen A Cronin; Lynne Penberthy; Betsy A Kohler
Journal:  Cancer       Date:  2016-03-09       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.